T2 Hypointense Basal Ganglia C4022743
An MRI finding where the basal ganglia appear darker than normal on certain imaging sequences. May indicate calcifications, iron deposits, or metabolic disorders. Additional testing helps identify the cause.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(neurologic)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Movement disorder
(neurologic)Cognitive decline
(neurologic)Behavioral changes
(neurologic)Speech difficulty
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Neuroimaging follow-up
Regular MRI monitoring of the basal ganglia lesion to track any changes in signal intensity, size, or associated findings. Includes clinical correlation with movement and cognitive function.
Movement disorder treatment
Pharmacological management of any associated movement symptoms such as tremor, dystonia, or parkinsonism. Treatment tailored to specific symptomatology and underlying cause.
Additional treatment options
Neuropsychological support
Assessment and support for cognitive changes that may accompany basal ganglia pathology. Includes coping strategies, family education, and referral to support services as needed.
psychologicalDiagnostic workup and biopsy
Comprehensive evaluation including possible biopsy to determine the etiology of the basal ganglia finding. May involve neurology, neurosurgery, and pathology consultation.
procedureNeuroprotective lifestyle measures
Implementation of lifestyle factors that support brain health including regular aerobic exercise, cognitive stimulation, adequate sleep, and avoidance of neurotoxic substances.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is T2 Hypointense Basal Ganglia C4022743?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Schneider SA, Hargreaves P. MRI findings in basal ganglia disorders. Mov Disord Clin Pract. 2022.
European Academy of Neurology. Neuroimaging guidelines for movement disorders. Eur J Neurol. 2021.
Hayflick SJ, Kurian MA. Investigating T2 hypointensity in NBIA spectrum disorders. Neurology. 2020.
Abdelkerim A, Dray M. Metabolic causes of basal ganglia calcification and hypointensity. Radiol Clin North Am. 2023.
Medication Comparisons
Compare medications used to treat T2 Hypointense Basal Ganglia C4022743. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy